Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil

International Journal of Dermatology

Volumn 43, Issue 9, 2004, Pages 643-647

  Yoshioka, Márcia Cristina Naomi ^a,b   de Avelar Alchorne, Mauricio Mota ^a   Porro, Adriana Maria ^a   Tomimori Yamashita, Jane ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; BRAZIL; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG RESPONSE; FEMALE; FOLLOW UP; HELPER CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INCIDENCE; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PAPULE; PROGNOSIS; SEX DIFFERENCE; SEXUAL BEHAVIOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 4644231303     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02170.x     Document Type: Article

References (34)

1. Smith C, Lilly S, Mann KP, et al. AIDS-related malignancies. Ann Med 1998; 30: 323-344.
2. Ebrahim SH, Peterman TA, Zaidi AA, et al. Geography of AIDS-associated Kaposi's sarcoma in Europe. AIDS 1997; 11: 1739-1745.
3. Hermans P. Epidemiology, etiology and pathogenesis, clinical presentations and therapeutic approaches in Kaposi's sarcoma: 15 -year lessons from AIDS. Biomed Pharmacother 1998; 52: 440-446.
4. Schwartländer B, Horsburgh CR, Hamouda O, et al. Changes in the spectrum of AIDS-defining conditions and decrease in CD4+ lymphocyte counts as AIDS manifestations in Germany from 1986 to 1991. AIDS 1992; 6: 413-420.
5. Zeller V, Caumes E, Bossi P, et al. Aspects cliniques actuels de la maladie VIH/SIDA. Presse Med 2002; 31: 74-79.
6. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001; 37: 1188-1201.
7. Jones JL, Hanson DL, Dworkin MS, et al. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 24: 270-274.
8. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-1998: the EuroSIDA study. Lancet 2000; 356: 291-296.
9. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immunodeficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 1989; 7: 1201-1207.
10. Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. Arch Dermatol Syphil 1872; 4: 265-273 [English translation: CA-A Cancer J Clin 1982; 32: 342-347].
11. Friedman-Kien A, Lauberstein L, Marmor M, et al. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR 1981; 30: 305-308.
12. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 1415-1431.
13. Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981; 305: 1431-1438.
14. Siegal FP, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305: 1439-1444.
15. Friedman-Kien AE. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol 1981; 5: 468-471.
16. Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 1990; 22: 1237-1250.
17. Hymes KB, Greene JB, Marcus A, et al. Kaposi's sarcoma in homosexual men: a report of eight cases. Lancet 1981; 2: 598-600.
18. Chang Y, Cesarman E, Penin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
19. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993; 28: 371-395.
20. Centers For Disease Control. First 500,000 AIDS cases - United States, 1995. MMWR 1995; 44: 849-853.
21. Ministério da Saúde. Boletim epidemiológico. AIDS 2000; 2: 9-19.
22. Archibald CP, Schechter MT, Craib KJ, et al. Risk factors for Kaposi's sarcoma in the Vancouver lymphadenopathy-AIDS study. J Acquir Immune Defic Syndr 1990; 3 (Suppl. 1): S18-S23.
23. Beral V, Peterman TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123-128.
24. Orfanos CE, Husak R, Wölfer U, et al. Kaposi's sarcoma: a reevaluation. Recent Results Cancer Res 1995; 139: 275-296.
25. Serraino D, Zaccarelli M, Franceschi S, et al. The epidemiology of AIDS-associated Kaposi's sarcoma in Italy. AIDS 1992; 6: 1015-1020.
26. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342: 1027-1038.
27. Jacobson LP, Munoz AP, Fox R, et al. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1: the Multicenter AIDS Cohort Study Group. J Acquir Immune Defic Syndr 1990; 3 (Suppl. 1): S24-S31.
28. Lyter DW, Bryant J, Thackeray R, et al. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995; 13: 2540-2546.
29. Tirelli U, Bernardi D. Impact of HAART on the clinical management of AIDS-related cancers. Eur J Cancer 2001; 37: 1320-1324.
30. Dupin N, Cervens VR, Gorin I, et al. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma. Br J Dermatol 1999; 140: 875-881.
31. Jacobson LP, Yamashita TE, Detels R, et al. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-I-infected individuals. J AIDS 1999; 21: S34-S41.
32. Zalla MJ. Kaposi's sarcoma: an update. Dermatol Surg 1996; 22: 274-287.
33. Lundgren JD, Melbye M, Pedersen C, et al. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up: the Danish Study Group for HIV Infection (DASHI). Am J Epidemiol 1995; 141: 652-658.
34. Rappersberger K, Wolfe K, Stingl G. Kaposi's sarcoma. In: Fitzpatrick TB, Eisen AZ, Wolfe K, et al., eds. Dermatology in General Medicine, 4th edn, Vol. I. New York: McGraw-Hill, 1993: 1244-1256.